CAMBRIDGE, Mass.--(BUSINESS WIRE)--Red Herring today announced that Pervasis Therapeutics, Inc., a pioneer in regenerative cell-based therapies and technologies, is a Finalist for the Red Herring 100 Award, a selection of the 100 private companies based in North America that play a leading role in innovation and technology
